The medical technology world is always changing with new advancements on the horizon. Recently, the FDA approved the first over-the-counter continuous glucose monitoring system, making it more accessible to those who may benefit from this technology. Continuous glucose monitors (CGM) are designed to constantly monitor blood sugar levels and are typically used by individuals who require insulin, such as those with type 1 or type 2 diabetes.
Traditionally, CGMs have been prescribed by healthcare providers. However, the newly approved Dexcom Stelo Glucose Biosensor System is now available for purchase at local stores, allowing individuals to take control of their own health. This system is intended for use by individuals 18 years and older, including those who do not use insulin but wish to track their blood sugar levels for health reasons.
The Dexcom Stelo system is a wearable sensor that can be paired with a mobile app for easy access to real-time data. Dr. Nasir Khan, an attending physician at the Erie County Medical Center, highlights the benefits of instant feedback provided by the device. However, he also cautions against becoming overly fixated on checking blood sugar levels, emphasizing the importance of balance in managing one’s health.
It’s important to note that the FDA has specified that this newly approved continuous glucose monitoring system is not suitable for individuals with problematic hypoglycemia. As such, it’s crucial to consult with a healthcare professional before using such devices. With technology continuing to revolutionize healthcare, innovations like the Dexcom Stelo Glucose Biosensor System offer new possibilities for managing chronic conditions and promoting overall well-being.
As healthcare evolves and technology continues to advance rapidly, there are new opportunities emerging in medical technology that can help people manage chronic conditions and improve their overall wellbeing. One such innovation is continuous glucose monitoring systems like Dexcom Stelo Glucose Biosensor System which has recently received FDA approval for over-the-counter sale.
Continuous glucose monitors (CGM) are designed to constantly monitor blood sugar levels and are typically used by individuals who require insulin due to conditions like type 1 or type 2 diabetes.
Traditionally, CGMs have been prescribed by healthcare providers but now they can be purchased at local stores making them more accessible than ever before.
The Dexcom Stelo system is a wearable sensor that can be paired with a mobile app for easy access to real-time data.
Dr. Nasir Khan highlights the benefits of instant feedback provided by the device but cautions against becoming too fixated on checking blood sugar levels while emphasizing balance in managing one’s health.
However, it’s important to note that this newly approved continuous glucose monitoring system is not suitable for individuals with problematic hypoglycemia; therefore consulting with a healthcare professional before using such devices is crucial.
